Kiely M.,Laval University |
Kiely M.,Public Health Quebec Institute |
Sauvageau C.,Laval University |
Sauvageau C.,Public Health Quebec Institute |
And 4 more authors.
Human Vaccines and Immunotherapeutics | Year: 2013
Human papillomavirus (HP V) infections are the most common sexually transmitted infections in North America and are associated with cervical cancer. A publicly-funded HP V immunization program was launched in the province of Quebec, Canada, in the fall of 2008. The aim of this study was to explore factors associated with HP V immunization among young adult women not targeted by this program. Results: Few women had received at least one dose of HP V vaccine among the 1347 respondents. Age at first sexual intercourse ≥ 20 y, participating in cervical cancer screening, higher education level, being born in Quebec and some positive beliefs about HP V were associated with vaccination. Methods: A questionnaire was mailed to 2400 24-y-old women randomly selected from the Quebec provincial health insurance database and 56% responded. Factors associated with vaccination status were analyzed using a multivariate logistic regression model. Conclusions: The rate of immunization in women who had to pay for the HP V vaccine was very low and was associated with characteristics that are generally associated with a lower risk for HP V infection and cervical cancer. Efforts are needed to reach at-risk adult women. © 2013 Landes Bioscience. Source